8-K
Current Report
C4 Therapeutics, Inc. Filed Acc 0001628280-25-032155
Bylaws or fiscal year change · Shareholder vote results
- Item 5.03 Amendments to articles or bylaws; change in fiscal year
- Item 5.07 Submission of matters to a vote of security holders
From the SEC's structured data for this filing
Loading cccc-20250618.htm…